|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 14, 2018 ) Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast.
https://www.marketsandmarkets.com/Market-Reports/metabolic-testing-equipment-market-149228862.html
According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 billion in 2003 to $7,163.64 billion in 2012, at a CAGR of 7.39%. During this period, the public healthcare spending increased at a CAGR of 7.82%, from $2,182.47 billion in 2003 to $4,285.10 billion in 2012. On the other hand, the global population increased at a CAGR of 1.19%, from 6,302 million in 2003 to 7,008 million in 2012. The per capita healthcare spending also increased from $598 in 2003 to $1,022 in 2012, at a CAGR of 6.13%. Increase in healthcare expenditure is an important growth driver for the metabolic testing market.
The report provides a granular understanding of the metabolic testing market. This report segments the global market on the basis of products, technologies, applications, and end users. In 2014, the CPET systems product segment accounted for the largest share of the market. The VO2 max analysis, lifestyle diseases, and hospitals segments accounted for the largest shares of this market, by technology, application, and user, respectively.
The global metabolic testing market is segmented on the basis of products, technologies, and applications. CPET system was the largest product segment while VO2 max analysis was the largest technology segment in 2014. VO2 max assessment is an important parameter for metabolic testing and is one of the most widely prescribed metabolic tests for athletes, healthy individuals, as well as patients. The lifestyle diseases application segment accounted for the largest share of the global metabolic testing market owing to the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity.
The geographic segments included in the report are Asia, Europe, North America, and the Rest of the World (RoW). Geographic analysis reveals that North America accounted for the largest share of the global metabolic market in 2014. Growth in this market can be attributed to the rising prevalence of lifestyle diseases. The Asian regional segment, on the other hand, is expected to register a higher growth rate from 2014 to 2019, owing to the rising standard of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about healthcare in this region.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=149228862
The major players of this market are CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Request for customization:
https://www.marketsandmarkets.com/requestCustomization.asp?id=149228862
Contact:
Mr. Shelly Singh
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
